Photocure ASA PHCUF:OTCPK

RT Quote | Exchange | USD
Last | 04/28/22 EDT
12.20UNCH (UNCH)
52 week range
9.14 - 17.57
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.20
  • 52 Week High17.57
  • 52 Week High Date06/15/21
  • 52 Week Low9.14
  • 52 Week Low Date04/13/22

Key Stats

  • Market Cap274.72M
  • Shares Out26.96M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.20
  • 52 Week High17.57
  • 52 Week High Date06/15/21
  • 52 Week Low9.14
  • 52 Week Low Date04/13/22
  • Market Cap274.72M
  • Shares Out26.96M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.13
  • P/E (TTM)-93.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Photocure ASA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Photocure ASA is a Norway-based company active in the pharmaceutical industry. It operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection...
Jan Egberts
Chairman of the Board
Daniel Schneider
President, Chief Executive Officer
Erik Dahl
Chief Financial Officer
Anders Neijber M.D., Ph.D.
Vice President, Global Medical Affairs and Clinical Development
Grete Hogstad
Vice President Strategic Marketing
Address
Hoffsveien 4
Oslo
0275
Norway